Results 181 to 190 of about 598,834 (266)
Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system. [PDF]
Yu L, Xiang Q, Liu L.
europepmc +1 more source
Practical approach to determining costs and frequency of adverse drug events in a health care network [PDF]
Bonnie L. Senst+7 more
openalex +1 more source
In this randomized clinical trial conducted among 142 community‐dwelling older adults at high risk for falls over 12 months, a Dalcroze Eurhythmics exercise intervention (once weekly, group‐based) improved a variety of physical and cognitive/executive function outcomes compared with a multicomponent exercise intervention (twice weekly, group‐ and home ...
Mélany Hars+7 more
wiley +1 more source
Peripheral polyneuropathy in patients receiving long-term statin therapy
Öner Özdogan
doaj +1 more source
Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess. [PDF]
Luo H+7 more
europepmc +1 more source
The Epidemiology of Major Early Adverse Physiological Events After Surgery
K. James+4 more
openalex +1 more source
Minimizing perioperative adverse events in the elderly [PDF]
Fengling Jin, Frances Chung
openalex +1 more source
Current and Future Cornea Chip Models for Advancing Ophthalmic Research and Therapeutics
This review analyzes cornea chip technology as an innovative solution to corneal blindness and tissue scarcity. The examination encompasses recent developments in biomaterial design and fabrication methods replicating corneal architecture, highlighting applications in drug screening and disease modeling while addressing key challenges in mimicking ...
Minju Kim+3 more
wiley +1 more source
A disproportionality analysis of FDA adverse event reporting system events for misoprostol. [PDF]
Yang L, Xu W.
europepmc +1 more source